About
NAD+ Pharmaceuticals
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
98
By Phase
PHASE1: 2
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
Today
Hover over trial bars to see details
Recent Trials
NCT03650075Lead Sponsor
To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers
PHASE1Completed
81 participants
Started: Feb 25, 2019 · Completed: Feb 27, 2020
NCT03406364Lead Sponsor
Assess the Safety and Activity of Combined MG005 and Sorafenib (NEXAVAR®) Treatment With Solid Tumor
PHASE1Completed
17 participants
Started: Jun 6, 2018 · Completed: Jul 24, 2020